close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about SNY

Recent news which mentions SNY

< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
FDA Approves Sanofi's Enzyme Therapy For Late-Onset Pompe Disease
Tickers SNY
Tags Benzinga Biotech FDA
From Benzinga
Exicure Shares Interim Cavrotolimod Data From Early-Stage Trial In Solid Tumor Patients
Tickers MRK REGN SNY XCUR
Tags Health Care Market News SNY
From Benzinga
Sanofi - Regeneron's Libtayo/Chemo Treatment Improves Overall Survival First-Line Lung Cancer
Tickers REGN SNY
Tags Briefs Trading Ideas Biotech
From Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Tickers ABSI ABUS ACAD ACXP
Tags GH SLRX NVO
From Benzinga
How This Historic FDA Approval Benefits Viatris
Tickers ABBV RVNC SNY VTRS
Tags SNY RVNC ABBV
From Motley Fool
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
Tickers ABSI ACET AERI AKRO
Tags PRAX ACET CPRX
From Benzinga
Why Translate Bio Stock Soared Today
Tickers SNY TBIO
Tags SNY TBIO Market News
From Motley Fool
Mid-Afternoon Market Update: Dow Jumps Over 200 Points; Neuronetics Shares Plunge
Tickers ABVC ARCT BABA CPG
Tags ABVC Markets Eurozone
From Benzinga
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
Tickers ABSI ACET ADCT ADVM
Tags OTLK Penny Stocks PFE
From Benzinga
Sanofi Bets Big On mRNA Push With Translate Bio Acquisition For $3.2B: Highlights
Tickers SNY TBIO
Tags SNY Movers Health Care
From Benzinga
Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates
Tickers ALBO AXSM CARA CCXI
Tags Penny Stocks General PFE
From Benzinga
Sanofi (SNY) Q2 2021 Earnings Call Transcript
Tickers SNY
Tags Market News SNY
From Motley Fool
The Daily Biotech Pulse: Merck's Disappointing Q2, Atreca Falls On Data, FDA Nod For Viatris, Nuvalent, Icosavax IPOs
Tickers ABBV ABOS ACET AGIO
Tags TBIO NUVL RGEN
From Benzinga
Sanofi Q2 Performance Benefits From Dupixent, Vaccines; Raises 2021 Profit Forecast
Tickers SNY
Tags Briefs Earnings Guidance
From Benzinga
Regeneron - Sanofi's Dupixent Improves Itch, Hives In Inflammatory Skin Disease Patients
Tickers REGN SNY
Tags Health Care Market News SNY
From Benzinga
Earnings Scheduled For July 29, 2021
Tickers MPW MRC MRK MSTR
Tags MSTR THRM SBH
From Benzinga
Sanofi's Pompe Disease Enzyme Replacement Therapy Gets EMA's CHMP Backing
Tickers CHMP SNY
Tags FDA Biotech Benzinga
From Benzinga
7 Cheap Value Stocks to Buy for August 2021
Tickers AMZN BRK-A BRK-B CVS
Tags PRU UNM MET
From InvestorPlace
Sanofi-Regeneron's COPD Drug Fails In Mid-Stage Trial, But Shows Potential Benefit In Subgroup of Former Smokers
Tickers ANY REGN SNY
Tags General News SNY
From Benzinga
15 European Dividend Aristocrats to Diversify Your Portfolio
Tickers ASHTY BTI CLPBY DEO
Tags UL WTKWY KRYAY
From InvestorPlace
EMA Starts Rolling Review Of Glaxo - Sanofi COVID-19 Vaccine
Tickers CVAC GSK NVAX SNY
Tags SVA Briefs General
From Benzinga
Sanofi's Oral Treatment For Sleeping Sickness Gets FDA Approval
Tickers SNY
Tags Health Care Market News SNY
From Benzinga
5 French Stocks To Consider For Bastille Day
Tickers BRRLY CRTO DANOY GSK
Tags BRRLY Tiffany & Co/ LVMH
From Benzinga
Is This Coronavirus Stock Undervalued?
Tickers REGN SNY
Tags SNY Market News REGN
From Motley Fool
New Developments Have Made Vaxart Stock So Much More Attractive
Tickers SNY VXRT
Tags SNY VXRT NASDAQ:VXRT,NYSE:SNY
From InvestorPlace
Sanofi, GSK Get Nod For Late-Stage COVID-19 Vaccine Trial In India
Tickers GSK SNY
Tags Briefs Biotech GSK
From Benzinga
< Previous 1 2
...
23 24 25 26 27 28 29 30 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today